Cell Kinetics Ltd.
Other OTCTotal Valuation
Cell Kinetics Ltd. carries a market capitalization of 100,000.00, placing it among publicly traded companies globally. Its enterprise value stands at -4,000.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 100,000.00 |
| Enterprise Value | -4,000.00 |
Share Statistics
Cell Kinetics Ltd. currently has 16.50M shares outstanding.
| Shares Outstanding | 16.50M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Cell Kinetics Ltd. maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -74.39 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Income Statement
EBITDA reached -475,000.00, while operating income came in at -475,000.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -475,000.00 |
| Pretax Income | N/A |
| Net Income | -2.10M |
| EBITDA | -475,000.00 |
| EBIT | -475,000.00 |
| Earnings Per Share (EPS) | -0.13 |
Balance Sheet
Total book value stands at -60.51M, with working capital of -246,000.00 providing operational flexibility.
| Cash & Cash Equivalents | 4,000.00 |
| Total Debt | N/A |
| Net Debt | -4,000.00 |
| Equity (Book Value) | -60.51M |
| Book Value Per Share | -3.69 |
| Working Capital | -246,000.00 |
Scores
Cell Kinetics Ltd. posts an Altman Z-Score of -120.83, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -120.83 |